chrX-137566825-A-ACGC
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP3BP6BS2
The ENST00000287538.10(ZIC3):c.159_161dup(p.Ala54dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00409 in 1,160,230 control chromosomes in the GnomAD database, including 10 homozygotes. There are 1,071 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.0025 ( 1 hom., 59 hem., cov: 24)
Exomes 𝑓: 0.0043 ( 9 hom. 1012 hem. )
Consequence
ZIC3
ENST00000287538.10 inframe_insertion
ENST00000287538.10 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 1.41
Genes affected
ZIC3 (HGNC:12874): (Zic family member 3) This gene encodes a member of the ZIC family of C2H2-type zinc finger proteins. This nuclear protein probably functions as a transcription factor in early stages of left-right body axis formation. Mutations in this gene cause X-linked visceral heterotaxy, which includes congenital heart disease and left-right axis defects in organs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP3
Nonframeshift variant in repetitive region in ENST00000287538.10
BP6
Variant X-137566825-A-ACGC is Benign according to our data. Variant chrX-137566825-A-ACGC is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 259047.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=1}.
BS2
High Hemizygotes in GnomAd4 at 59 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZIC3 | NM_003413.4 | c.159_161dup | p.Ala54dup | inframe_insertion | 1/3 | ENST00000287538.10 | NP_003404.1 | |
ZIC3 | NM_001330661.1 | c.159_161dup | p.Ala54dup | inframe_insertion | 1/3 | NP_001317590.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZIC3 | ENST00000287538.10 | c.159_161dup | p.Ala54dup | inframe_insertion | 1/3 | 1 | NM_003413.4 | ENSP00000287538 | P1 | |
ZIC3 | ENST00000370606.3 | c.159_161dup | p.Ala54dup | inframe_insertion | 1/3 | 5 | ENSP00000359638 |
Frequencies
GnomAD3 genomes AF: 0.00247 AC: 276AN: 111757Hom.: 1 Cov.: 24 AF XY: 0.00173 AC XY: 59AN XY: 34145
GnomAD3 genomes
AF:
AC:
276
AN:
111757
Hom.:
Cov.:
24
AF XY:
AC XY:
59
AN XY:
34145
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00205 AC: 198AN: 96477Hom.: 2 AF XY: 0.00157 AC XY: 51AN XY: 32583
GnomAD3 exomes
AF:
AC:
198
AN:
96477
Hom.:
AF XY:
AC XY:
51
AN XY:
32583
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00426 AC: 4468AN: 1048430Hom.: 9 Cov.: 33 AF XY: 0.00297 AC XY: 1012AN XY: 341090
GnomAD4 exome
AF:
AC:
4468
AN:
1048430
Hom.:
Cov.:
33
AF XY:
AC XY:
1012
AN XY:
341090
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00247 AC: 276AN: 111800Hom.: 1 Cov.: 24 AF XY: 0.00173 AC XY: 59AN XY: 34198
GnomAD4 genome
AF:
AC:
276
AN:
111800
Hom.:
Cov.:
24
AF XY:
AC XY:
59
AN XY:
34198
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:3
Likely benign, no assertion criteria provided | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Nov 02, 2015 | - - |
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Heterotaxy, visceral, 1, X-linked Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 12, 2023 | - - |
ZIC3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 21, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at